<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25706647</article-id><article-id pub-id-type="pmc">4338261</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0115855</article-id><article-id pub-id-type="publisher-id">PONE-D-14-41738</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>MicroRNA 21 Is a Homeostatic Regulator of Macrophage Polarization and Prevents Prostaglandin E<sub>2</sub>-Mediated M2 Generation</article-title><alt-title alt-title-type="running-head">MicroRNA 21 Inhibits M2 Polarization</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhuo</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brandt</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Medeiros</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Soujuan</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dent</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Serezani</surname><given-names>C. Henrique</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Departamento de Ci&#x000ea;ncias Biol&#x000f3;gicas, Faculdade de Ci&#x000ea;ncias Farmac&#x000ea;uticas, Universidade Estadual Paulista &#x0201c;J&#x000fa;lio de Mesquita Filho,&#x0201d; 14801&#x02013;902 Araraquara, S&#x000e3;o Paulo, Brazil</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Bozza</surname><given-names>Patricia T.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Funda&#x000e7;&#x000e3;o Oswaldo Cruz, BRAZIL</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: ZW SB AM SW. Performed the experiments: ZW SB AM SW HW. Analyzed the data: ZW SB AM SW HW AD CHS. Contributed reagents/materials/analysis tools: AD CHS. Wrote the paper: CHS.</p></fn><corresp id="cor001">* E-mail: <email>hserezan@iu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>e0115855</elocation-id><history><date date-type="received"><day>23</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>2</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Wang et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0115855.pdf"/><abstract><p>Macrophages dictate both initiation and resolution of inflammation. During acute inflammation classically activated macrophages (M1) predominate, and during the resolution phase alternative macrophages (M2) are dominant. The molecular mechanisms involved in macrophage polarization are understudied. MicroRNAs are differentially expressed in M1 and M2 macrophages that influence macrophage polarization. We identified a role of miR-21 in macrophage polarization, and found that cross-talk between miR-21 and the lipid mediator prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) is a determining factor in macrophage polarization. miR-21 inhibition impairs expression of M2 signature genes but not M1 genes. PGE<sub>2</sub> and its downstream effectors PKA and Epac inhibit miR-21 expression and enhance expression of M2 genes, and this effect is more pronounced in miR-21-/- cells. Among potential targets involved in macrophage polarization, we found that STAT3 and SOCS1 were enhanced in miR-21-/- cells and further enhanced by PGE<sub>2</sub>. We found that STAT3 was a direct target of miR-21 in macrophages. Silencing the STAT3 gene abolished PGE<sub>2</sub>-mediated expression of M2 genes in miR-21-/- macrophages. These data shed light on the molecular brakes involved in homeostatic macrophage polarization and suggest new therapeutic strategies to prevent inflammatory responses.</p></abstract><funding-group><funding-statement>This work was supported by National Institutes of Health Grants 1R21AI079349-01 (to A.D.), HL-103777&#x02013;01 and HL-124159-01 (C.H.S.) and T32AI060519 (to S.B.), Ralph W. and Grace M. Showalter Research Trust Fund and Funda&#x000e7;&#x000e3;o de Amparo a Pesquisa do Estado de S&#x000e3;o Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="13"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Macrophages are pleiotropic cells that can function as immune effectors and regulators, tissue remodelers, or scavengers [<xref rid="pone.0115855.ref001" ref-type="bibr">1</xref>]. The acute inflammatory response is characterized by the presence of M1 macrophages, and the chronic or resolution inflammatory phases are mediated by the enrichment of M2 macrophages [<xref rid="pone.0115855.ref002" ref-type="bibr">2</xref>]. While microbial products such as LPS and the proinflammatory cytokines TNF-&#x003b1; and IFN-induce M1 macrophages, M2 macrophages are generated in the presence of IL-4, IL-13 or IL-10 [<xref rid="pone.0115855.ref003" ref-type="bibr">3</xref>]. M1 are known to enhance microbial clearance and to enhance cell recruitment to the inflammatory focus by secreting TNF-&#x003b1;, IL-1&#x003b2;, and nitric oxide, and M2 macrophages are known to enhance fungal phagocytosis and to secrete pro-resolution substances including fibronectin, IL-10, TGF-&#x003b2;, and metalloproteases [<xref rid="pone.0115855.ref002" ref-type="bibr">2</xref>].</p><p>Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) is an endogenous lipid mediator produced in abundance at sites of inflammation and infection, and itself modulates many aspects of macrophage function [<xref rid="pone.0115855.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0115855.ref006" ref-type="bibr">6</xref>]. The immunomodulatory effects of PGE<sub>2</sub> in macrophages largely result from its ability to increase intracellular cAMP through the stimulatory G protein (G<sub>s</sub>)-coupled E prostanoid (EP) receptors EP2 and EP4 [<xref rid="pone.0115855.ref007" ref-type="bibr">7</xref>]. Increases in intracellular cAMP levels activate two downstream effector molecules, cAMP-dependent protein kinase A (PKA) and the exchange protein directly activated by cAMP-1 (Epac-1) [<xref rid="pone.0115855.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0115855.ref010" ref-type="bibr">10</xref>]. Increases in intracellular cAMP generally suppress innate immune functions of macrophages, including suppressing the generation of inflammatory mediators such as TNF-&#x003b1; and the phagocytosis and killing of microbes [<xref rid="pone.0115855.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0115855.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0115855.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0115855.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>]. However, the role of PGE<sub>2</sub> in the generation of M1 or M2 macrophages is poorly understood. Depending on the cell type investigated, the PGE<sub>2</sub>/EP2-EP4/cAMP/PKA cascade has been shown to enhance, inhibit, or exert no effect on iNOS expression [<xref rid="pone.0115855.ref009" ref-type="bibr">9</xref>], an M1 marker, and PGE<sub>2</sub> has been shown to enhance the production of IL-10 and IL-6 [<xref rid="pone.0115855.ref009" ref-type="bibr">9</xref>], which generates M2 macrophages. The molecular mechanisms by which PGE<sub>2</sub> enhances the generation of M2 macrophages remain to be determined.</p><p>MicroRNAs are small oligonucleotides (&#x0223c; 22 nt) that bind complementary sequences in mRNAs, usually resulting in gene silencing via translational repression or target degradation [<xref rid="pone.0115855.ref015" ref-type="bibr">15</xref>]. Recent studies have shown that microRNAs are key determinants of macrophage activation, controlling the expression of a variety of molecules involved in PRR signaling and NF&#x003ba;B activation [<xref rid="pone.0115855.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0115855.ref023" ref-type="bibr">23</xref>]. Different microRNAs are expressed in M1 or M2 polarized macrophages and have been shown to control macrophage polarization [<xref rid="pone.0115855.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="pone.0115855.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0115855.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0115855.ref029" ref-type="bibr">29</xref>]. The role of miR-21 in macrophage polarization is unknown but numerous properties of miR21 have been described. miR-21 expression is enhanced by inflammatory stimuli, including LPS stimulation. miR-21 impairs MyD88-dependent NF&#x003ba;B activation and IL-6 expression, but enhances IL-10 expression [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. miR-21 targets the proinflammatory molecule tumor suppressor programmed cell death protein 4 [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. miR-21 targets other proinflammatory cytokines, such as IL-12p35, during allergic inflammation [<xref rid="pone.0115855.ref031" ref-type="bibr">31</xref>]. miR-21 -/- mice exhibit lower levels of TNF-&#x003b1;, MIP-2, and NF&#x003ba;B p65 in a model of fatal colitis [<xref rid="pone.0115855.ref032" ref-type="bibr">32</xref>].</p><p>Since PGE<sub>2</sub> exerts anti-inflammatory effects in macrophages by inhibiting TNF-&#x003b1; and enhancing IL-10 levels [<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0115855.ref033" ref-type="bibr">33</xref>], and lack of miR-21 exhibits similar effects, we sought to investigate possible interplay between miR-21 and PGE<sub>2</sub> that might lead to macrophage polarization. We found that macrophages from miR-21 deficient mice are enriched in M2 macrophages and depleted of M1 macrophages. Furthermore, miR-21 deficiency potentiates PGE<sub>2</sub>-mediated M2 macrophages in a STAT3-dependent manner.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>miR-21 drives M1 and inhibits M2 peritoneal macrophage polarization</title><p>The role of miR-21 in the control of macrophage polarization remains to be determined. Initially we determined the expression profile of M1 and M2 markers by real time PCR in thioglycollate-elicited macrophages. Our data showed that the M1 markers <italic>Tnfa, Il12p40, Il1b</italic>, and <italic>Il6</italic> were either not detected or were detected at lower levels than observed in WT macrophages <bold>(<xref rid="pone.0115855.g001" ref-type="fig">Fig. 1A</xref>)</bold>. We found that all M2 markers studied (<italic>Il10, Arg1, Retnla</italic>, and <italic>Chi3l3</italic>) were enhanced in miR-21-/- macrophages when compared to WT macrophages <bold>(<xref rid="pone.0115855.g001" ref-type="fig">Fig. 1A</xref>)</bold>. These same genotype-specific patterns of expression were observed in resident peritoneal and alveolar macrophages (data not shown). Thus, further experiments were performed only in elicited macrophages. We confirmed that miR-21 inhibited the expression of genes present in M2 macrophages and enhances the expression of genes enriched in M1 macrophages by treating WT cells with the miR-21 mimic <bold>(<xref rid="pone.0115855.g001" ref-type="fig">Fig. 1B</xref> and inset)</bold>. Our findings indicate that miR-21 is a homeostatic regulator of macrophage polarization even in the absence of conventional M1 or M2 stimuli.</p><fig id="pone.0115855.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0115855.g001</object-id><label>Fig 1</label><caption><title>miR-21 deficiency impairs M1 and favors M2 macrophage polarization.</title><p>
<bold>(A)</bold> Thioglycollate-elicited macrophages from WT and miR-21 deficient mice were isolated, and the expression of <italic>Tnfa, Il12p40, Il1b, Arg1, Il10, IL-6, Retnla, Chi3l3</italic>, and <italic>Actin</italic> mRNA was determined by real time PCR. <bold>(B)</bold> Elicited macrophages were transfected with the miR-21mimic or the scrambled control (30 nM each), and the expression of <italic>Retnla, Arg1</italic>,<italic>Tnfa, Il1b</italic> and <italic>Actin</italic> was determined by real time PCR. Inset: miR-21 mRNA expression of macrophages transfected as in <bold>B</bold>. Data represent mean &#x000b1; SEM from 3&#x02013;5 individual experiments, each performed in triplicate. *<italic>p</italic> &#x0003c; 0.05 versus WT cells or mimic control.</p></caption><graphic xlink:href="pone.0115855.g001"/></fig></sec><sec id="sec004"><title>PGE<sub>2</sub> inhibits miR-21 expression in macrophages</title><p>Previously, we have shown that PGE<sub>2</sub> enhances <italic>Il10</italic> and <italic>Il6</italic> production in a PKA dependent manner [<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0115855.ref034" ref-type="bibr">34</xref>]. However, the role of PGE<sub>2</sub> and its downstream effectors in macrophage polarization is poorly understood. Furthermore, whether PGE<sub>2</sub> controls microRNA expression remains to be determined. We found that PGE<sub>2</sub> inhibited miR-21 expression both at 4 and 24 h of stimulation compared to untreated cells <bold>(<xref rid="pone.0115855.g002" ref-type="fig">Fig. 2A</xref>)</bold>. Next, we sought to determine which cAMP downstream effector, PKA or Epac, inhibited miR-21 expression. We stimulated macrophages with the PKA agonist 6-Bnz-cAMP or Epac agonist 8-pCPT-2-<italic>O</italic>-Me-cAMP for different times and found that both effectors inhibited miR-21 expression. However, while PKA activation was more potent in inhibiting miR-21 at earlier time points, Epac activation was more effective in reducing miR-21 expression after 24 h of activation <bold>(<xref rid="pone.0115855.g002" ref-type="fig">Fig. 2B</xref>)</bold>. These results suggest that distinct cAMP effectors that influence different transcriptional programs differentially inhibit miR-21 expression.</p><fig id="pone.0115855.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0115855.g002</object-id><label>Fig 2</label><caption><title>PGE<sub>2</sub>/PKA/Epac axis inhibits miR-21 expression in macrophages.</title><p>Elicited macrophages were treated or not with 1 &#x003bc;M PGE<sub>2</sub>
<bold>(A)</bold> or 500 &#x003bc;M of PKA-specific cAMP analog 6-Bnz-cAMP or Epac-specific cAMP analog 8-pCPT-2-O-Me-cAMP each <bold>(B)</bold> for the indicated times, and the expression of miR-21 was determined by real time PCR. Data represent mean &#x000b1; SEM from 3&#x02013;5 individual experiments, each performed in triplicate. *<italic>p</italic> &#x0003c; 0.05 versus unstimulated cells; # p&#x0003c;0.05 versus cells stimulated with PKA.</p></caption><graphic xlink:href="pone.0115855.g002"/></fig></sec><sec id="sec005"><title>miR-21 is an endogenous brake in PGE<sub>2</sub>-mediated M2 polarization</title><p>To study the profile of macrophage polarization in PGE<sub>2</sub>-stimulated macrophages, WT cells were challenged with PGE<sub>2</sub> for 4 and 24 h, and the profiles of M1 and M2-related genes in macrophages were determined by real time PCR. We found that PGE<sub>2</sub> decreased the expression of M1 markers <italic>Tnfa</italic> and <italic>Nos2</italic>
<bold>(<xref rid="pone.0115855.g003" ref-type="fig">Fig. 3 A and B</xref>)</bold> and enhanced the expression of M2 markers Arg1, <italic>Mmp2</italic>, and <italic>Chi3l3</italic>. While Arg1 expression was more pronounced 4 h after PGE<sub>2</sub> stimulation, the expression of <italic>Mmp2</italic> and <italic>Chi3l3</italic> were higher 24 h after PGE<sub>2</sub> stimulation <bold>(<xref rid="pone.0115855.g003" ref-type="fig">Fig. 3 C-E</xref>)</bold>. When miR-21 deficient macrophages were tested, we observed that PGE<sub>2</sub> further enhanced M2 markers 24h after stimulation compared to M2 marker expression in WT cells <bold>(<xref rid="pone.0115855.g003" ref-type="fig">Fig. 3 C-E</xref>)</bold>. These data suggest that PGE<sub>2</sub> enhances M2 markers, and that miR-21 acts as an endogenous brake involved in the PGE<sub>2</sub>-mediated generation of M2 cells.</p><fig id="pone.0115855.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0115855.g003</object-id><label>Fig 3</label><caption><title>Absence of miR-21 amplifies PGE<sub>2</sub>-mediated M2 polarization.</title><p>Thioglycollate-elicited macrophages from WT and miR-21 deficient mice were stimulated or not with PGE<sub>2</sub> for 4 or 24 h, and the expression of <italic>Tnfa, Nos2, Arg1, Mmp2</italic>, and <italic>Chi3l3</italic> mRNA was determined by real time PCR. Data represent mean &#x000b1; SEM from 3&#x02013;5 individual experiments, each performed in triplicate. *<italic>p</italic> &#x0003c; 0.05 versus unstimulated cells and p&#x0003c;0.05 versus WT macrophages; # p &#x0003c; 0.05 versus WT cells stimulated with PGE<sub>2</sub> for 24h.</p></caption><graphic xlink:href="pone.0115855.g003"/></fig></sec><sec id="sec006"><title>miR-21 targets STAT3 to inhibit M2 polarization</title><p>To understand the mechanisms involved in miR-21 inhibition of macrophage polarization, we initially determined the expression profiles of proteins and transcription factors involved in M1 and M2 polarization. We found that 24 h after PGE<sub>2</sub> challenge the expression of STAT3 and STAT1 but not STAT6 was enhanced in WT macrophages <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 A and B</xref>)</bold>. We also observed an increase in STAT3 expression in miR-21 -/- macrophages, which PGE<sub>2</sub> treatment enhanced further <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 A</xref>)</bold>. We did not observe changes in the expression of NF&#x003ba;B p65, SOCS3, MyD88, or TIRAP <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 A</xref>)</bold>. We found that PGE<sub>2</sub> treatment enhanced SOCS-1 expression levels in both miR-21 -/- and WT macrophages <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 A</xref>)</bold>. Enhanced STAT3 expression also correlated with increased STAT3 phosphorylation, but not STAT1 and STAT6 activation.</p><fig id="pone.0115855.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0115855.g004</object-id><label>Fig 4</label><caption><title>miR-21 targets STAT3 in macrophages.</title><p>
<bold>(A)</bold> Thioglycollate-elicited macrophages from WT and miR-21 deficient mice were stimulated or not with PGE<sub>2</sub> for the indicated times, and the expression of STAT3, STAT1, SOCS1, SOCS2, SOCS3, TIRAP, NF&#x003ba;B p65, and beta actin was determined by immunoblotting. <bold>(B)</bold> Elicited macrophages from WT and miR-21 deficient mice were stimulated or not with PGE<sub>2</sub> for 24 h, and the expression of t-STAT6, pSTAT6 (Tyr641), pSTAT1 (Tyr701), pSTAT3 (Tyr705) and beta actin was determined by immunoblotting. <bold>(C)</bold> Elicited macrophages from WT were transfected with 30 nM of scrambled control, miR-21, or miR-21 antagomir for 24 h, followed by determination of STAT3, MyD88, SOCS1, and beta-actin by immunoblotting. The numbers represent mean densitometric analysis of the bands shown from 3 independent experiments. The dashed line in the figure indicates lanes in the membrane that contained experimental conditions that were run under the same experimental conditions but not pertinent and were omitted. Data are mean &#x000b1; SEM; *<italic>p &#x0003c;</italic> 0.01 versus WT scrambled control-treated cells. <bold>(D)</bold> Raw264.7 macrophages were transfected with a luciferase construct containing the 3&#x02032; UTR of STAT3 and empty vector expressing luciferase reporter plasmid followed by the microRNA mimic miR-21 (30 nM) for 24 h, and luciferase activity was determined. Inset: The predicted miR-21 seed sequence located in the 3&#x02032;-UTR of STAT3. Sequence alignment of miR-21 and STAT3 is shown, and matches are indicated by a line. Data represent mean &#x000b1; SEM from at least 3 individual experiments, each performed in triplicate. *<italic>p</italic> &#x0003c; 0.05 versus empty vector.</p></caption><graphic xlink:href="pone.0115855.g004"/></fig><p>To further confirm that miR-21 targeted STAT3, we determined the expression of STAT3 in WT macrophages treated with miR-21 mimic or with the miR-21 antagomir <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4C</xref>)</bold>. The miR-21 mimic inhibited STAT3 expression, and the antagomir further enhanced STAT3 expression <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 C</xref>)</bold>, indicating the miR-21 targeted STAT3 expression. We then look at the protein expression of the M2 marker SOCS1 and the M1 marker SOCS3 [<xref rid="pone.0115855.ref035" ref-type="bibr">35</xref>&#x02013;<xref rid="pone.0115855.ref037" ref-type="bibr">37</xref>]. We found that the miR-21 mimic inhibited SOCS-1 expression while the antagomir enhanced SOCS-1 expression. Neither the mimic nor antagomir affected the expression of MyD88 <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 C</xref>)</bold>. To further confirm that miR-21 directly targeted STAT3 3&#x02019;UTR sequences, we transfected RAW 264.6 cells with a plasmid expressing STAT3&#x02013;3&#x02019;UTR luciferase or empty vector, followed by transfection of cells with miR-21 mimic or scrambled mimic. We found that miR-21 directly inhibited STAT3 expression, indicating that miR-21 targeted STAT3&#x02013;3&#x02019;UTR sequences <bold>(<xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 D</xref>)</bold>. The inset shows the predicted miR-21 seed sequence in the STAT3&#x02013;3&#x02019;UTR <bold>(<ext-link ext-link-type="uri" xlink:href="http://www.microRNA.org">www.microRNA.org</ext-link>; <xref rid="pone.0115855.g004" ref-type="fig">Fig. 4 D</xref>)</bold>.</p></sec><sec id="sec007"><title>STAT3 mediates PGE<sub>2</sub>-induction of M2 macrophages in miR-21 deficient macrophages</title><p>Since STAT3 expression was enhanced in miR-21 -/- macrophages and PGE<sub>2</sub> stimulation further enhanced STAT3 in these cells, we determined whether enhanced STAT3 expression in miR-21 -/- cells stimulated with PGE<sub>2</sub> influenced M2 polarization. We silenced STAT3 in both WT and miR-21 deficient cells (<xref rid="pone.0115855.g005" ref-type="fig">Fig. 5A</xref>). We then stimulated with PGE<sub>2</sub> and determined expression of M2-markers by real time PCR <bold>(<xref rid="pone.0115855.g005" ref-type="fig">Fig. 5B-E</xref>)</bold>. When STAT3 was silenced in WT macrophages, we did not observe changes in M2 markers <bold>(<xref rid="pone.0115855.g005" ref-type="fig">Fig. 5B-E</xref>)</bold>. Furthermore, STAT3 depletion did not prevent expression of M2 genes in PGE<sub>2</sub>-stimulated WT macrophages, indicating that STAT3 does not mediate homeostatic M2 polarization <bold>(<xref rid="pone.0115855.g005" ref-type="fig">Fig. 5B-E</xref>)</bold>. While Stat3 silencing did not change the expression of M2 markers in WT cells, Stat3 inhibition in miR-21 -/- macrophages inhibited the expression of <italic>Chi3l3</italic> and enhanced <italic>Retnla</italic> and <italic>Il6</italic> mRNA expression. While Stat3 silencing abolished PGE<sub>2</sub>-enhanced expression of <italic>Chi3l3, Retnla</italic>, and <italic>Il6</italic> in miR-21 -/- cells, we did not observe an effect of <italic>Stat3</italic> inhibition on <italic>Il10</italic> expression. These results indicate that increased M2 polarization in PGE<sub>2</sub>-stimulated miR-21 -/- cells is dependent on STAT3 signaling.</p><fig id="pone.0115855.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0115855.g005</object-id><label>Fig 5</label><caption><title>PGE<sub>2</sub> utilizes STAT3 signaling to enhance M2 macrophages in miR-21 deficient macrophages.</title><p>WT and miR-21 deficient macrophages were treated with 30 nM STAT3 siRNA or siRNA control for 24 h and stimulated or not with PGE<sub>2</sub> for another 24 h. Expression of <bold>(A)</bold>
<italic>Stat3</italic>, <bold>(B)</bold>
<italic>Chi3l3</italic>, <bold>(C)</bold>
<italic>Retnla</italic>, and <bold>(D)</bold>
<italic>Il6</italic>, <bold>(E)</bold>
<italic>Il10</italic> mRNA were determined by real time PCR. <bold>(F)</bold> Proposed model of miR-21 and PGE2-mediated M2 macrophage generation. Data represent mean &#x000b1; SEM from at least 3 individual experiments, each performed in triplicate. *<italic>p</italic> &#x0003c; 0.05 versus WT siControl; <sup>#</sup>p&#x0003c;0.05 versus miR-21 -/- cells and <sup>&#x00026;</sup>p&#x0003c;0.05 versus STAT3 siRNA control.</p></caption><graphic xlink:href="pone.0115855.g005"/></fig></sec></sec><sec sec-type="conclusions" id="sec008"><title>Discussion</title><p>This study highlights a novel regulatory mechanism of homeostatic M2 macrophage polarization along the PGE<sub>2</sub>/cAMP axis mediated by miR-21 <bold>(<xref rid="pone.0115855.g005" ref-type="fig">Fig. 5F</xref>)</bold>. We and others have shown that PGE<sub>2</sub> inhibits TNF-&#x003b1; production and enhances IL-10 levels in macrophages from different anatomical sites [<xref rid="pone.0115855.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0115855.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0115855.ref038" ref-type="bibr">38</xref>]. miR-21 deficiency also leads to low TNF-&#x003b1; and enhanced IL-10 production in macrophages [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0115855.ref039" ref-type="bibr">39</xref>]. Here, we extended these findings by investigating cross-talk between PGE<sub>2</sub> and miR-21 in the development of macrophage anti-inflammatory effects and the molecular programs involved. We found that: 1) miR-21 deficiency inhibits the expression of M1 and enhanced M2 markers in elicited peritoneal macrophages; 2) PGE<sub>2</sub>/PKA/Epac inhibited miR-21 expression; 3) PGE<sub>2</sub> enhances the expression of M2 markers, and its effects are enhanced in miR-21 deficient cells; 4) miR-21/PGE<sub>2</sub> targets STAT3 and SOCS1, but not STAT1, STAT6, SOCS3, or TLR adaptors; 5) STAT3 silencing prevents PGE<sub>2</sub>-induced M2 marker expression in miR-21 deficient cells.</p><p>M1 macrophages are classically induced by IFN-&#x003b3; and LPS, and M2 macrophages are induced by IL4 and IL-13 [<xref rid="pone.0115855.ref039" ref-type="bibr">39</xref>]. Furthermore, M2 macrophages can be further classified in M2a, M2b and M2c, depending on the stimuli. Here, we show that depletion of a single microRNA led to inhibition of M1 and enhanced M2 markers in the absence of any stimuli, indicating that miR-21 functions to keep macrophage polarization in check, and depletion of this microRNA favors the expression of M2 markers. Whether miR-21 differentially regulates specific M2 populations remains to be determined. The results showed that effects of miR-21 in the deficient mice were not the consequence of a putative compensatory mechanism that might influence the expression of different microRNAs. That miR-21 controls LPS actions has been shown. Sheedy et al have shown that miR-21 inhibits the production of IL-6 and enhances IL-10 levels by controlling both NF&#x003ba;B p65 levels and the proinflammatory molecule tumor suppressor programmed cell death 4 (PDCD4), an inhibitor of IL-10 production [<xref rid="pone.0115855.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. These findings are not in perfect agreement with ours, since we found that miR-21 -/- elicited macrophages show enhanced IL-6 and IL-10 levels, whereas Sheedy et al. show that miR-21 mimic enhances IL-6 and decrease IL-10 levels [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. The reason for this discrepancy is uncertain, but there are several differences in the respective experiments. Sheedy et al studied miR-21 effects in a macrophage cell line and bone marrow derived macrophages; whereas, we performed our experiments in thioglycollate-elicited macrophages, which exhibit an inflammatory phenotype [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. Also, we investigated the role of miR-21 in basal/homeostatic expression of these cytokines, and Sheedy et al determined the production of IL-16 and IL-10 in LPS-stimulated cells [<xref rid="pone.0115855.ref030" ref-type="bibr">30</xref>]. Whether thioglycollate-elicited miR-21 deficient macrophages respond to LPS in the same manner as cell lines or bone marrow macrophages remains to be determined. Our results are in agreement with Shi et al. who showed in a model of colitis that M1-like cytokines such as TNF-&#x003b1;and MIP-2 are decreased in miR-21 deficient mice [<xref rid="pone.0115855.ref032" ref-type="bibr">32</xref>]. Clearly, the elucidation of such cell-specific functions of miR-21 should help in the development of effective miR-based therapeutic strategies.</p><p>Here, we investigated the role of the cAMP inducer PGE<sub>2</sub> in the expression of miR-21 in macrophages. Our data show that PGE<sub>2</sub> challenge decreased miR-21 expression, and incubation of macrophages with the downstream effectors PKA or the Epac agonist also decreased miR-21 levels. Whether the cAMP/PKA/Epac axis influences global microRNA expression and their effects in macrophage biology remains to be determined. These data lead us to speculate that miR-21 acts as a brake on PGE<sub>2</sub> effects, and PGE<sub>2</sub>-mediated miR-21 inhibition is part of an inhibitory loop involved in macrophage M2 polarization by the PGE<sub>2</sub>/PKA/Epac axis.</p><p>The molecular mechanisms involved in miR-21 and PGE<sub>2</sub>-induced M2 macrophages were studied. Initially, we tested whether miR-21 inhibition influenced EP 1&#x02013;4 mRNA expression, but we did not observe any differences in the expression of these receptors between WT and miR-21 -/- cells or WT cells treated with miR-21 mimic (data not shown). We also did not observe any change in the expression of the CREB (data not shown). We next investigated which transcription factors and effectors were involved in enhanced expression of M2 genes. While STAT6 is activated by IL-4 and IL-13 [<xref rid="pone.0115855.ref040" ref-type="bibr">40</xref>], and has been suggested to be the master regulator of M2 differentiation, STAT1 and NF&#x003ba;B are thought to be essential for M1 generation [<xref rid="pone.0115855.ref040" ref-type="bibr">40</xref>]. We did not observe a change in the expression of STAT6 and phosphorylation in miR-21-/- macrophages, which led us to study the expression of other STAT proteins in miR-21 deficient cells, and to ask whether PGE<sub>2</sub> further influenced the expression of these proteins. We found that STAT3 and STAT1 levels were enhanced in miR-21-/- macrophages, and treatment with PGE<sub>2</sub> further enhanced STAT3 expression and phosphorylation, but not STAT1 activation when compared to WT cells. That miR-21 expression is controlled by STAT3 has been shown [<xref rid="pone.0115855.ref041" ref-type="bibr">41</xref>&#x02013;<xref rid="pone.0115855.ref043" ref-type="bibr">43</xref>]; however, whether miR-21 controls STAT3 levels is unknown. We found that miR-21 -/- and miR-21 antagomir transfection enhanced STAT3 levels, and conversely, miR-21 mimic decreased STAT3. Whether miR-21 directly targets SOCS1 and whether STAT3 controls SOCS1 levels in a PGE<sub>2</sub> dependent manner is under investigation.</p><p>PGE<sub>2</sub> is known to control STAT3 activation and expression [<xref rid="pone.0115855.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pone.0115855.ref047" ref-type="bibr">47</xref>]. However, whether PGE<sub>2</sub> utilizes STAT3 to inhibit macrophage function is poorly understood. Here, we found that Stat3 silencing abolished PGE<sub>2</sub>-enhanced expression of <italic>Chi3l3, Retnla</italic>, and <italic>Il6</italic> in miR-21 -/- cells, we did not observe an effect of Stat3 inhibition on <italic>Il10</italic> expression. The mechanisms involved in PGE<sub>2</sub>-induced STAT3 activation in macrophages remain to be determined. Frias et al, have shown that PGE<sub>2</sub> enhances STAT3 phosphorylation in a manner dependent on ERK 1/2 activation but not on p38 MAPK activation [<xref rid="pone.0115855.ref044" ref-type="bibr">44</xref>,<xref rid="pone.0115855.ref048" ref-type="bibr">48</xref>]. Singh et al showed that PGE<sub>2</sub> enhances STAT3 expression [<xref rid="pone.0115855.ref049" ref-type="bibr">49</xref>]. Another potential mechanism by which PGE<sub>2</sub> enhances M2 dependent genes in a STAT3 dependent manner is through the production of Il6, which is known to induce STAT3 activation [<xref rid="pone.0115855.ref050" ref-type="bibr">50</xref>&#x02013;<xref rid="pone.0115855.ref052" ref-type="bibr">52</xref>] and M2 generation [<xref rid="pone.0115855.ref053" ref-type="bibr">53</xref>]. Pretreatment of both PGE<sub>2</sub> stimulated WT and miR-21 cells with anti-IL-6 did not prevent PGE<sub>2</sub> effects on the expression of M2 genes (data not shown). Therefore, it still remains to be determined how PGE<sub>2</sub> influences the expression of M2 dependent genes, and how miR-21 interferes with PGE<sub>2</sub> signaling.</p><p>Effects of microRNAs on cytokine signaling and their consequences for macrophage biology may be a root cause of inflammation [<xref rid="pone.0115855.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0115855.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0115855.ref055" ref-type="bibr">55</xref>]. There are numerous approved pharmaceuticals that target STAT3. As well, specific microRNA mimics or antagomirs are also known to control the inflammatory response [<xref rid="pone.0115855.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0115855.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0115855.ref055" ref-type="bibr">55</xref>], and the use of such microRNAs to treat inflammatory diseases represents a potent therapeutic approach. In conditions were acute inflammation needs to be controlled, miR-21 antagomirs may be a good therapeutic agents that increase the numbers of M2 macrophages and decrease the expression of master inflammatory mediators such as IL-1&#x003b2; and TNF-&#x003b1;. Alternatively, miR-21 mimics could block chronic inflammatory responses by preventing M2 formation. In view of its role in inflammation, additional studies investigating the role of this microRNA in acute and chronic models of inflammation are warranted.</p></sec><sec sec-type="materials|methods" id="sec009"><title>Methods</title><sec id="sec010"><title>Animals</title><p>8-week-old female WT C57BL/6 mice (The Jackson Laboratory) or miR-21 deficient mice (miR-21 -/-) and counterpart WT [<xref rid="pone.0115855.ref056" ref-type="bibr">56</xref>] were maintained according to NIH guidelines for the use of experimental animals with the approval of the Indiana University School of Medicine Animal Care and Use Committees (Protocol Number: 10238). Surgical procedures were performed under isofluorane anesthesia and all necessary steps to minimize suffering were taken.</p></sec><sec id="sec011"><title>Cell harvest and stimulation</title><p>Elicited macrophages were harvested from the peritoneal cavities of mice by lavage with PBS 4 days after the injection of 2 ml 3% thioglycollate as described previously [<xref rid="pone.0115855.ref008" ref-type="bibr">8</xref>]. Macrophages were stimulated with 1 &#x003bc;M PGE<sub>2</sub> [<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0115855.ref033" ref-type="bibr">33</xref>] or 500 &#x003bc;M PKA-specific cAMP analog 6-Bnz-cAMP (<italic>N</italic>
<sup>6</sup>-benzoyladenosine-3&#x02032;,5&#x02032;-cyclic monophosphate), or Epac-specific cAMP analog 8-pCPT-2-O-Me-cAMP (8&#x02013;4-chlorophenylthio)-2&#x02032;-O-methyladenosine-3&#x02032;,5&#x02032;-cyclic monophosphate) [<xref rid="pone.0115855.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0115855.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0115855.ref034" ref-type="bibr">34</xref>] for 24 h followed by RNA or protein isolation.</p></sec><sec id="sec012"><title>Immunoblotting</title><p>Western blots were performed as previously described [<xref rid="pone.0115855.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0115855.ref009" ref-type="bibr">9</xref>]. Protein samples were resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and probed with commercially available primary antibodies against STAT3, STAT1, TIRAP, MyD88, NF&#x003ba;B p65, SOCS-1-3 (all at 1:500; Abcam), phosphorylated STAT3 (Tyr705), STAT1 (Tyr701) and STAT6 (Tyr641) (all at 1:1000; Cell Signaling) or <bold>&#x003b2;</bold>-actin (1:10,000; Sigma-Aldrich). Densitometric analysis was performed as described previously [<xref rid="pone.0115855.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0115855.ref009" ref-type="bibr">9</xref>].</p></sec><sec id="sec013"><title>RNA analysis</title><p>Total RNA from cultured cells was isolated using the miRNeasy Mini Kit (Qiagen) according to the manufacturer&#x02019;s instructions. Quantitative RT-PCR analyses for miR-21 and RNU6 (used as a normalization control) were performed using TaqMan miRNA assays with reagents, primers, and probes obtained from Qiagen. In brief, a stem loop primer was used for reverse transcription (30 min, 16&#x000b0;C; 30 min, 42&#x000b0;C; 5 min 85&#x000b0;C) followed by qPCR employing TaqMan probes and primers in a Bio-rad CFX96 Mastercycler. For assessing expression of <italic>Socs1, Myd88, Stat3, Il10, Chi3l3, Il6, Retnla, Nos2, Tnfa, Arg1, Mmp2</italic>, and <italic>actin</italic>, cDNA was synthesized using a reverse transcription system (miScript II&#x02014;Qiagem). qPCR was performed on a CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories) as described [<xref rid="pone.0115855.ref009" ref-type="bibr">9</xref>]. Primers were purchased from Integrated DNA technologies. Relative expression was calculated using the comparative threshold cycle (Ct) and expressed relative to control or WT (&#x00394;&#x00394;Ct method).</p></sec><sec id="sec014"><title>Targeted miRNA inhibition and overexpression</title><p>For inhibition of miR-21, macrophages were transfected using lipofectamine siRNA max transfection reagents with appropriate target anti-miR-21 antagomir or anti-miR-negative control 1 (anti-miR-control) [<xref rid="pone.0115855.ref057" ref-type="bibr">57</xref>]. For overexpression, macrophages were transfected with pre-miR-21 or pre-miR-negative control 1 (pre-miR-control) [<xref rid="pone.0115855.ref057" ref-type="bibr">57</xref>]. Transfection reagents, antagomirs, and control miRNAs were purchased from Invitrogen. Knockdown efficiency and overexpression efficiency were assessed by determining mature miR-21 levels in transfected cells. Transfected cells were treated with or without 30 nM microRNA mimic or antagomir for 48 h before collecting supernatants or preparing cell lysates for isolation of RNA (RNeasy kit, Qiagen) or proteins.</p></sec><sec id="sec015"><title>Luciferase assays</title><p>Plasmids containing the 3&#x02032;UTR of murine STAT3 were purchased from Genecopeia. The Raw 264.7 macrophage cell line was transfected with constructs in 6-well plates using lipofectamine siRNA max (Invitrogen). Firefly luciferase reporter gene constructs (0.1 &#x003bc;g per well) were co-transfected together with 30 nM of miR-21 or scrambled-miR control; cells were lysed 24 h after transfection, and luciferase activity was measured. Each sample was assayed in triplicate as described [<xref rid="pone.0115855.ref057" ref-type="bibr">57</xref>].</p></sec><sec id="sec016"><title>Statistics</title><p>Data are presented as mean &#x000b1; SEM. Comparisons among groups were assessed with ANOVA followed by Bonferroni analysis; <italic>p</italic> &#x0003c; 0.05 was considered significant.</p></sec></sec></body><back><ack><p>This work was supported by National Institutes of Health Grants 1R21AI079349-01 (to A. D.), HL-103777-01 and HL-124159-01 (C. H. S.) and T32AI060519 (to S.B.), Ralph W. and Grace M. Showalter Research Trust Fund and Funda&#x000e7;&#x000e3;o de Amparo a Pesquisa do Estado de S&#x000e3;o Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0115855.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Galli</surname><given-names>SJ</given-names></name>, <name><surname>Borregaard</surname><given-names>N</given-names></name>, <name><surname>Wynn</surname><given-names>TA</given-names></name> (<year>2011</year>) <article-title>Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils</article-title>. <source>Nat Immunol</source>
<volume>12</volume>: <fpage>1035</fpage>&#x02013;<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2109</pub-id>
<pub-id pub-id-type="pmid">22012443</pub-id></mixed-citation></ref><ref id="pone.0115855.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Murray</surname><given-names>PJ</given-names></name>, <name><surname>Wynn</surname><given-names>TA</given-names></name> (<year>2011</year>) <article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>: <fpage>723</fpage>&#x02013;<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1038/nri3073</pub-id>
<pub-id pub-id-type="pmid">21997792</pub-id></mixed-citation></ref><ref id="pone.0115855.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Edwards</surname><given-names>JP</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Frauwirth</surname><given-names>KA</given-names></name>, <name><surname>Mosser</surname><given-names>DM</given-names></name> (<year>2006</year>) <article-title>Biochemical and functional characterization of three activated macrophage populations</article-title>. <source>J Leukoc Biol</source>
<volume>80</volume>: <fpage>1298</fpage>&#x02013;<lpage>1307</lpage>.
<pub-id pub-id-type="pmid">16905575</pub-id></mixed-citation></ref><ref id="pone.0115855.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Medeiros</surname><given-names>AI</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Lee</surname><given-names>SP</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling</article-title>. <source>J Exp Med</source>
<volume>206</volume>: <fpage>61</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20082058</pub-id>
<pub-id pub-id-type="pmid">19124657</pub-id></mixed-citation></ref><ref id="pone.0115855.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Chung</surname><given-names>J</given-names></name>, <name><surname>Ballinger</surname><given-names>MN</given-names></name>, <name><surname>Moore</surname><given-names>BB</given-names></name>, <name><surname>Aronoff</surname><given-names>DM</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase</article-title>. <source>Am J Respir Cell Mol Biol</source>
<volume>37</volume>: <fpage>562</fpage>&#x02013;<lpage>570</lpage>.
<pub-id pub-id-type="pmid">17585108</pub-id></mixed-citation></ref><ref id="pone.0115855.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Zaslona</surname><given-names>Z</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Okunishi</surname><given-names>K</given-names></name>, <name><surname>Aronoff</surname><given-names>DM</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling</article-title>. <source>Blood</source>
<volume>119</volume>: <fpage>2358</fpage>&#x02013;<lpage>2367</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-08-374207</pub-id>
<pub-id pub-id-type="pmid">22234697</pub-id></mixed-citation></ref><ref id="pone.0115855.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Aronoff</surname><given-names>DM</given-names></name>, <name><surname>Hao</surname><given-names>Y</given-names></name>, <name><surname>Chung</surname><given-names>J</given-names></name>, <name><surname>Coleman</surname><given-names>N</given-names></name>, <name><surname>Lewis</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii</article-title>. <source>J Immunol</source>
<volume>180</volume>: <fpage>8222</fpage>&#x02013;<lpage>8230</lpage>.
<pub-id pub-id-type="pmid">18523288</pub-id></mixed-citation></ref><ref id="pone.0115855.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Medeiros</surname><given-names>A</given-names></name>, <name><surname>Peres-Buzalaf</surname><given-names>C</given-names></name>, <name><surname>Fortino</surname><given-names>Verdan F</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name> (<year>2012</year>) <article-title>Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs</article-title>. <source>Mediators Inflamm</source>
<volume>2012</volume>: <fpage>327568</fpage>
<pub-id pub-id-type="pmid">23024463</pub-id></mixed-citation></ref><ref id="pone.0115855.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>SH</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Okunishi</surname><given-names>K</given-names></name>, <name><surname>Zaslona</surname><given-names>Z</given-names></name>, <name><surname>Aronoff</surname><given-names>DM</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>8875</fpage>&#x02013;<lpage>8883</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.187815</pub-id>
<pub-id pub-id-type="pmid">21247892</pub-id></mixed-citation></ref><ref id="pone.0115855.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>SP</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Medeiros</surname><given-names>AI</given-names></name>, <name><surname>Ballinger</surname><given-names>MN</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP</article-title>. <source>J Immunol</source>
<volume>182</volume>: <fpage>530</fpage>&#x02013;<lpage>537</lpage>.
<pub-id pub-id-type="pmid">19109185</pub-id></mixed-citation></ref><ref id="pone.0115855.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Aronoff</surname><given-names>DM</given-names></name>, <name><surname>Jancar</surname><given-names>S</given-names></name>, <name><surname>Mancuso</surname><given-names>P</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name> (<year>2005</year>) <article-title>Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase</article-title>. <source>Blood</source>
<volume>106</volume>: <fpage>1067</fpage>&#x02013;<lpage>1075</lpage>.
<pub-id pub-id-type="pmid">15718414</pub-id></mixed-citation></ref><ref id="pone.0115855.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Flamand</surname><given-names>N</given-names></name>, <name><surname>Mancuso</surname><given-names>P</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Brock</surname><given-names>TG</given-names></name> (<year>2007</year>) <article-title>Leukotrienes: mediators that have been typecast as villains</article-title>. <source>Cell Mol Life Sci</source>
<volume>64</volume>: <fpage>2657</fpage>&#x02013;<lpage>2670</lpage>.
<pub-id pub-id-type="pmid">17639273</pub-id></mixed-citation></ref><ref id="pone.0115855.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Brock</surname><given-names>TG</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Carstens</surname><given-names>JK</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name>, <name><surname>Aronoff</surname><given-names>DM</given-names></name> (<year>2008</year>) <article-title>Effects of prostaglandin E2 on the subcellular localization of Epac-1 and Rap1 proteins during Fcgamma-receptor-mediated phagocytosis in alveolar macrophages</article-title>. <source>Exp Cell Res</source>
<volume>314</volume>: <fpage>255</fpage>&#x02013;<lpage>263</lpage>.
<pub-id pub-id-type="pmid">18021770</pub-id></mixed-citation></ref><ref id="pone.0115855.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Morato-Marques</surname><given-names>M</given-names></name>, <name><surname>Campos</surname><given-names>MR</given-names></name>, <name><surname>Kane</surname><given-names>S</given-names></name>, <name><surname>Rangel</surname><given-names>AP</given-names></name>, <name><surname>Lewis</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Leukotrienes target F-actin/cofilin-1 to enhance alveolar macrophage anti-fungal activity</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>28902</fpage>&#x02013;<lpage>28913</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.235309</pub-id>
<pub-id pub-id-type="pmid">21715328</pub-id></mixed-citation></ref><ref id="pone.0115855.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>O'Neill</surname><given-names>LA</given-names></name>, <name><surname>Sheedy</surname><given-names>FJ</given-names></name>, <name><surname>McCoy</surname><given-names>CE</given-names></name> (<year>2011</year>) <article-title>MicroRNAs: the fine-tuners of Toll-like receptor signalling</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>: <fpage>163</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/nri2957</pub-id>
<pub-id pub-id-type="pmid">21331081</pub-id></mixed-citation></ref><ref id="pone.0115855.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>G</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Xing</surname><given-names>Y</given-names></name>, <name><surname>Wei</surname><given-names>J</given-names></name>, <name><surname>Ge</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>MicroRNA-149 negatively regulates TLR-triggered inflammatory response in macrophages by targeting MyD88</article-title>. <source>J Cell Biochem</source>
<volume>115</volume>: <fpage>919</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.24734</pub-id>
<pub-id pub-id-type="pmid">24375488</pub-id></mixed-citation></ref><ref id="pone.0115855.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Banerjee</surname><given-names>S</given-names></name>, <name><surname>Cui</surname><given-names>H</given-names></name>, <name><surname>Xie</surname><given-names>N</given-names></name>, <name><surname>Tan</surname><given-names>Z</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>miR-125a-5p regulates differential activation of macrophages and inflammation</article-title>. <source>J Biol Chem</source>
<volume>288</volume>: <fpage>35428</fpage>&#x02013;<lpage>35436</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.426866</pub-id>
<pub-id pub-id-type="pmid">24151079</pub-id></mixed-citation></ref><ref id="pone.0115855.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Wei</surname><given-names>J</given-names></name>, <name><surname>Huang</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Jia</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>MyD88 as a target of microRNA-203 in regulation of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage RAW264.7 cells</article-title>. <source>Mol Immunol</source>
<volume>55</volume>: <fpage>303</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2013.03.004</pub-id>
<pub-id pub-id-type="pmid">23522925</pub-id></mixed-citation></ref><ref id="pone.0115855.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Mardente</surname><given-names>S</given-names></name>, <name><surname>Mari</surname><given-names>E</given-names></name>, <name><surname>Consorti</surname><given-names>F</given-names></name>, <name><surname>Di Gioia</surname><given-names>C</given-names></name>, <name><surname>Negri</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells</article-title>. <source>Oncol Rep</source>
<volume>28</volume>: <fpage>2285</fpage>&#x02013;<lpage>2289</lpage>. <pub-id pub-id-type="doi">10.3892/or.2012.2058</pub-id>
<pub-id pub-id-type="pmid">23023232</pub-id></mixed-citation></ref><ref id="pone.0115855.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Gantier</surname><given-names>MP</given-names></name>, <name><surname>Stunden</surname><given-names>HJ</given-names></name>, <name><surname>McCoy</surname><given-names>CE</given-names></name>, <name><surname>Behlke</surname><given-names>MA</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>A miR-19 regulon that controls NF-kappaB signaling</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>: <fpage>8048</fpage>&#x02013;<lpage>8058</lpage>.
<pub-id pub-id-type="pmid">22684508</pub-id></mixed-citation></ref><ref id="pone.0115855.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Bala</surname><given-names>S</given-names></name>, <name><surname>Marcos</surname><given-names>M</given-names></name>, <name><surname>Kodys</surname><given-names>K</given-names></name>, <name><surname>Csak</surname><given-names>T</given-names></name>, <name><surname>Catalano</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>1436</fpage>&#x02013;<lpage>1444</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.145870</pub-id>
<pub-id pub-id-type="pmid">21062749</pub-id></mixed-citation></ref><ref id="pone.0115855.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>RS</given-names></name>, <name><surname>Hu</surname><given-names>GQ</given-names></name>, <name><surname>Lin</surname><given-names>B</given-names></name>, <name><surname>Lin</surname><given-names>ZY</given-names></name>, <name><surname>Sun</surname><given-names>CC</given-names></name> (<year>2010</year>) <article-title>MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages</article-title>. <source>J Investig Med</source>
<volume>58</volume>: <fpage>961</fpage>&#x02013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.231/JIM.0b013e3181ff46d7</pub-id>
<pub-id pub-id-type="pmid">21030878</pub-id></mixed-citation></ref><ref id="pone.0115855.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Friggeri</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Park</surname><given-names>YJ</given-names></name>, <name><surname>Tsuruta</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>: <fpage>15819</fpage>&#x02013;<lpage>15824</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0901216106</pub-id>
<pub-id pub-id-type="pmid">19721002</pub-id></mixed-citation></ref><ref id="pone.0115855.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Alam</surname><given-names>MM</given-names></name>, <name><surname>O'Neill</surname><given-names>LA</given-names></name> (<year>2011</year>) <article-title>MicroRNAs and the resolution phase of inflammation in macrophages</article-title>. <source>Eur J Immunol</source>
<volume>41</volume>: <fpage>2482</fpage>&#x02013;<lpage>2485</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201141740</pub-id>
<pub-id pub-id-type="pmid">21952801</pub-id></mixed-citation></ref><ref id="pone.0115855.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Arranz</surname><given-names>A</given-names></name>, <name><surname>Doxaki</surname><given-names>C</given-names></name>, <name><surname>Vergadi</surname><given-names>E</given-names></name>, <name><surname>Martinez de la</surname><given-names>Torre Y</given-names></name>, <name><surname>Vaporidi</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>9517</fpage>&#x02013;<lpage>9522</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1119038109</pub-id>
<pub-id pub-id-type="pmid">22647600</pub-id></mixed-citation></ref><ref id="pone.0115855.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Banerjee</surname><given-names>S</given-names></name>, <name><surname>Xie</surname><given-names>N</given-names></name>, <name><surname>Cui</surname><given-names>H</given-names></name>, <name><surname>Tan</surname><given-names>Z</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>MicroRNA let-7c Regulates Macrophage Polarization</article-title>. <source>J Immunol</source>
<volume>190</volume>: <fpage>6542</fpage>&#x02013;<lpage>6549</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1202496</pub-id>
<pub-id pub-id-type="pmid">23667114</pub-id></mixed-citation></ref><ref id="pone.0115855.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Graff</surname><given-names>JW</given-names></name>, <name><surname>Dickson</surname><given-names>AM</given-names></name>, <name><surname>Clay</surname><given-names>G</given-names></name>, <name><surname>McCaffrey</surname><given-names>AP</given-names></name>, <name><surname>Wilson</surname><given-names>ME</given-names></name> (<year>2012</year>) <article-title>Identifying functional microRNAs in macrophages with polarized phenotypes</article-title>. <source>J Biol Chem</source>
<volume>287</volume>: <fpage>21816</fpage>&#x02013;<lpage>21825</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.327031</pub-id>
<pub-id pub-id-type="pmid">22549785</pub-id></mixed-citation></ref><ref id="pone.0115855.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>El Gazzar</surname><given-names>M</given-names></name>, <name><surname>Church</surname><given-names>A</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>McCall</surname><given-names>CE</given-names></name> (<year>2011</year>) <article-title>MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming</article-title>. <source>J Leukoc Biol</source>
<volume>90</volume>: <fpage>509</fpage>&#x02013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0211074</pub-id>
<pub-id pub-id-type="pmid">21562054</pub-id></mixed-citation></ref><ref id="pone.0115855.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Jiang</surname><given-names>M</given-names></name>, <name><surname>Xiang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages</article-title>. <source>Aging Cell</source>
<volume>11</volume>: <fpage>29</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00757.x</pub-id>
<pub-id pub-id-type="pmid">21981419</pub-id></mixed-citation></ref><ref id="pone.0115855.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Sheedy</surname><given-names>FJ</given-names></name>, <name><surname>Palsson-McDermott</surname><given-names>E</given-names></name>, <name><surname>Hennessy</surname><given-names>EJ</given-names></name>, <name><surname>Martin</surname><given-names>C</given-names></name>, <name><surname>O'Leary</surname><given-names>JJ</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21</article-title>. <source>Nat Immunol</source>
<volume>11</volume>: <fpage>141</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1828</pub-id>
<pub-id pub-id-type="pmid">19946272</pub-id></mixed-citation></ref><ref id="pone.0115855.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Lu</surname><given-names>TX</given-names></name>, <name><surname>Munitz</surname><given-names>A</given-names></name>, <name><surname>Rothenberg</surname><given-names>ME</given-names></name> (<year>2009</year>) <article-title>MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression</article-title>. <source>J Immunol</source>
<volume>182</volume>: <fpage>4994</fpage>&#x02013;<lpage>5002</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803560</pub-id>
<pub-id pub-id-type="pmid">19342679</pub-id></mixed-citation></ref><ref id="pone.0115855.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Shi</surname><given-names>C</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury</article-title>. <source>PLoS One</source>
<volume>8</volume>: <fpage>e66814</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0066814</pub-id>
<pub-id pub-id-type="pmid">23826144</pub-id></mixed-citation></ref><ref id="pone.0115855.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Domingo-Gonzalez</surname><given-names>R</given-names></name>, <name><surname>Katz</surname><given-names>S</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Moore</surname><given-names>TA</given-names></name>, <name><surname>Levine</surname><given-names>AM</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant</article-title>. <source>J Immunol</source>
<volume>190</volume>: <fpage>5809</fpage>&#x02013;<lpage>5817</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1203274</pub-id>
<pub-id pub-id-type="pmid">23630358</pub-id></mixed-citation></ref><ref id="pone.0115855.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Rogers</surname><given-names>LM</given-names></name>, <name><surname>Thelen</surname><given-names>T</given-names></name>, <name><surname>Fordyce</surname><given-names>K</given-names></name>, <name><surname>Bourdonnay</surname><given-names>E</given-names></name>, <name><surname>Lewis</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii</article-title>. <source>Am J Reprod Immunol</source>
<volume>71</volume>: <fpage>34</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/aji.12153</pub-id>
<pub-id pub-id-type="pmid">23902376</pub-id></mixed-citation></ref><ref id="pone.0115855.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Spence</surname><given-names>S</given-names></name>, <name><surname>Fitzsimons</surname><given-names>A</given-names></name>, <name><surname>Boyd</surname><given-names>CR</given-names></name>, <name><surname>Kessler</surname><given-names>J</given-names></name>, <name><surname>Fitzgerald</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization</article-title>. <source>Immunity</source>
<volume>38</volume>: <fpage>66</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.013</pub-id>
<pub-id pub-id-type="pmid">23177319</pub-id></mixed-citation></ref><ref id="pone.0115855.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Qin</surname><given-names>H</given-names></name>, <name><surname>Holdbrooks</surname><given-names>AT</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Reynolds</surname><given-names>SL</given-names></name>, <name><surname>Yanagisawa</surname><given-names>LL</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>SOCS3 deficiency promotes M1 macrophage polarization and inflammation</article-title>. <source>J Immunol</source>
<volume>189</volume>: <fpage>3439</fpage>&#x02013;<lpage>3448</lpage>.
<pub-id pub-id-type="pmid">22925925</pub-id></mixed-citation></ref><ref id="pone.0115855.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Whyte</surname><given-names>CS</given-names></name>, <name><surname>Bishop</surname><given-names>ET</given-names></name>, <name><surname>Ruckerl</surname><given-names>D</given-names></name>, <name><surname>Gaspar-Pereira</surname><given-names>S</given-names></name>, <name><surname>Barker</surname><given-names>RN</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function</article-title>. <source>J Leukoc Biol</source>
<volume>90</volume>: <fpage>845</fpage>&#x02013;<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1110644</pub-id>
<pub-id pub-id-type="pmid">21628332</pub-id></mixed-citation></ref><ref id="pone.0115855.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Weinlich</surname><given-names>R</given-names></name>, <name><surname>Bortoluci</surname><given-names>KR</given-names></name>, <name><surname>Chehab</surname><given-names>CF</given-names></name>, <name><surname>Serezani</surname><given-names>CH</given-names></name>, <name><surname>Ulbrich</surname><given-names>AG</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>TLR4/MYD88-dependent, LPS-induced synthesis of PGE2 by macrophages or dendritic cells prevents anti-CD3-mediated CD95L upregulation in T cells</article-title>. <source>Cell Death Differ</source>
<volume>15</volume>: <fpage>1901</fpage>&#x02013;<lpage>1909</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2008.128</pub-id>
<pub-id pub-id-type="pmid">18820644</pub-id></mixed-citation></ref><ref id="pone.0115855.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Mosser</surname><given-names>DM</given-names></name>, <name><surname>Edwards</surname><given-names>JP</given-names></name> (<year>2008</year>) <article-title>Exploring the full spectrum of macrophage activation</article-title>. <source>Nat Rev Immunol</source>
<volume>8</volume>: <fpage>958</fpage>&#x02013;<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1038/nri2448</pub-id>
<pub-id pub-id-type="pmid">19029990</pub-id></mixed-citation></ref><ref id="pone.0115855.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Lawrence</surname><given-names>T</given-names></name>, <name><surname>Natoli</surname><given-names>G</given-names></name> (<year>2011</year>) <article-title>Transcriptional regulation of macrophage polarization: enabling diversity with identity</article-title>. <source>Nat Rev Immunol</source>
<volume>11</volume>: <fpage>750</fpage>&#x02013;<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1038/nri3088</pub-id>
<pub-id pub-id-type="pmid">22025054</pub-id></mixed-citation></ref><ref id="pone.0115855.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Iliopoulos</surname><given-names>D</given-names></name>, <name><surname>Jaeger</surname><given-names>SA</given-names></name>, <name><surname>Hirsch</surname><given-names>HA</given-names></name>, <name><surname>Bulyk</surname><given-names>ML</given-names></name>, <name><surname>Struhl</surname><given-names>K</given-names></name> (<year>2010</year>) <article-title>STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer</article-title>. <source>Mol Cell</source>
<volume>39</volume>: <fpage>493</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.07.023</pub-id>
<pub-id pub-id-type="pmid">20797623</pub-id></mixed-citation></ref><ref id="pone.0115855.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>CH</given-names></name>, <name><surname>Yue</surname><given-names>J</given-names></name>, <name><surname>Pfeffer</surname><given-names>SR</given-names></name>, <name><surname>Handorf</surname><given-names>CR</given-names></name>, <name><surname>Pfeffer</surname><given-names>LM</given-names></name> (<year>2011</year>) <article-title>MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>39172</fpage>&#x02013;<lpage>39178</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.285098</pub-id>
<pub-id pub-id-type="pmid">21940630</pub-id></mixed-citation></ref><ref id="pone.0115855.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Luo</surname><given-names>F</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Ling</surname><given-names>M</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells</article-title>. <source>Toxicol Appl Pharmacol</source>
<volume>273</volume>: <fpage>27</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2013.08.025</pub-id>
<pub-id pub-id-type="pmid">24004609</pub-id></mixed-citation></ref><ref id="pone.0115855.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Frias</surname><given-names>MA</given-names></name>, <name><surname>Somers</surname><given-names>S</given-names></name>, <name><surname>Gerber-Wicht</surname><given-names>C</given-names></name>, <name><surname>Opie</surname><given-names>LH</given-names></name>, <name><surname>Lecour</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis</article-title>. <source>Cardiovasc Res</source>
<volume>80</volume>: <fpage>69</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvn171</pub-id>
<pub-id pub-id-type="pmid">18567640</pub-id></mixed-citation></ref><ref id="pone.0115855.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Barclay</surname><given-names>JL</given-names></name>, <name><surname>Anderson</surname><given-names>ST</given-names></name>, <name><surname>Waters</surname><given-names>MJ</given-names></name>, <name><surname>Curlewis</surname><given-names>JD</given-names></name> (<year>2007</year>) <article-title>Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells</article-title>. <source>Mol Endocrinol</source>
<volume>21</volume>: <fpage>2516</fpage>&#x02013;<lpage>2528</lpage>.
<pub-id pub-id-type="pmid">17636039</pub-id></mixed-citation></ref><ref id="pone.0115855.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Cheon</surname><given-names>H</given-names></name>, <name><surname>Rho</surname><given-names>YH</given-names></name>, <name><surname>Choi</surname><given-names>SJ</given-names></name>, <name><surname>Lee</surname><given-names>YH</given-names></name>, <name><surname>Song</surname><given-names>GG</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Prostaglandin E2 augments IL-10 signaling and function</article-title>. <source>J Immunol</source>
<volume>177</volume>: <fpage>1092</fpage>&#x02013;<lpage>1100</lpage>.
<pub-id pub-id-type="pmid">16818766</pub-id></mixed-citation></ref><ref id="pone.0115855.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Rummel</surname><given-names>C</given-names></name>, <name><surname>Sachot</surname><given-names>C</given-names></name>, <name><surname>Poole</surname><given-names>S</given-names></name>, <name><surname>Luheshi</surname><given-names>GN</given-names></name> (<year>2006</year>) <article-title>Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>
<volume>291</volume>: <fpage>R1316</fpage>&#x02013;<lpage>1326</lpage>.
<pub-id pub-id-type="pmid">16809483</pub-id></mixed-citation></ref><ref id="pone.0115855.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Frias</surname><given-names>MA</given-names></name>, <name><surname>Rebsamen</surname><given-names>MC</given-names></name>, <name><surname>Gerber-Wicht</surname><given-names>C</given-names></name>, <name><surname>Lang</surname><given-names>U</given-names></name> (<year>2007</year>) <article-title>Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy</article-title>. <source>Cardiovasc Res</source>
<volume>73</volume>: <fpage>57</fpage>&#x02013;<lpage>65</lpage>.
<pub-id pub-id-type="pmid">17067562</pub-id></mixed-citation></ref><ref id="pone.0115855.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Singh</surname><given-names>P</given-names></name>, <name><surname>Hoggatt</surname><given-names>J</given-names></name>, <name><surname>Hu</surname><given-names>P</given-names></name>, <name><surname>Speth</surname><given-names>JM</given-names></name>, <name><surname>Fukuda</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells</article-title>. <source>Blood</source>
<volume>119</volume>: <fpage>1671</fpage>&#x02013;<lpage>1682</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-03-342428</pub-id>
<pub-id pub-id-type="pmid">22110249</pub-id></mixed-citation></ref><ref id="pone.0115855.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>MM</given-names></name>, <name><surname>Chui</surname><given-names>RK</given-names></name>, <name><surname>Tam</surname><given-names>IY</given-names></name>, <name><surname>Lau</surname><given-names>AH</given-names></name>, <name><surname>Wong</surname><given-names>YH</given-names></name> (<year>2012</year>) <article-title>CCR1-mediated STAT3 tyrosine phosphorylation and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Galpha(14/16) signaling and IL-6 release</article-title>. <source>J Immunol</source>
<volume>189</volume>: <fpage>5266</fpage>&#x02013;<lpage>5276</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1103359</pub-id>
<pub-id pub-id-type="pmid">23125416</pub-id></mixed-citation></ref><ref id="pone.0115855.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Dominguez-Soto</surname><given-names>A</given-names></name>, <name><surname>Sierra-Filardi</surname><given-names>E</given-names></name>, <name><surname>Puig-Kroger</surname><given-names>A</given-names></name>, <name><surname>Perez-Maceda</surname><given-names>B</given-names></name>, <name><surname>Gomez-Aguado</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10</article-title>. <source>J Immunol</source>
<volume>186</volume>: <fpage>2192</fpage>&#x02013;<lpage>2200</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1000475</pub-id>
<pub-id pub-id-type="pmid">21239715</pub-id></mixed-citation></ref><ref id="pone.0115855.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Tacke</surname><given-names>RS</given-names></name>, <name><surname>Tosello-Trampont</surname><given-names>A</given-names></name>, <name><surname>Nguyen</surname><given-names>V</given-names></name>, <name><surname>Mullins</surname><given-names>DW</given-names></name>, <name><surname>Hahn</surname><given-names>YS</given-names></name> (<year>2011</year>) <article-title>Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>10847</fpage>&#x02013;<lpage>10855</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.217653</pub-id>
<pub-id pub-id-type="pmid">21282107</pub-id></mixed-citation></ref><ref id="pone.0115855.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Mauer</surname><given-names>J</given-names></name>, <name><surname>Chaurasia</surname><given-names>B</given-names></name>, <name><surname>Goldau</surname><given-names>J</given-names></name>, <name><surname>Vogt</surname><given-names>MC</given-names></name>, <name><surname>Ruud</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin</article-title>. <source>Nat Immunol</source>
<volume>15</volume>: <fpage>423</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2865</pub-id>
<pub-id pub-id-type="pmid">24681566</pub-id></mixed-citation></ref><ref id="pone.0115855.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Bi</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Yang</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>MicroRNAs: novel regulators during the immune response</article-title>. <source>J Cell Physiol</source>
<volume>218</volume>: <fpage>467</fpage>&#x02013;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21639</pub-id>
<pub-id pub-id-type="pmid">19034913</pub-id></mixed-citation></ref><ref id="pone.0115855.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Abraham</surname><given-names>E</given-names></name> (<year>2013</year>) <article-title>MicroRNAs in immune response and macrophage polarization</article-title>. <source>Arterioscler Thromb Vasc Biol</source>
<volume>33</volume>: <fpage>170</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300068</pub-id>
<pub-id pub-id-type="pmid">23325473</pub-id></mixed-citation></ref><ref id="pone.0115855.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Hatley</surname><given-names>ME</given-names></name>, <name><surname>Patrick</surname><given-names>DM</given-names></name>, <name><surname>Garcia</surname><given-names>MR</given-names></name>, <name><surname>Richardson</surname><given-names>JA</given-names></name>, <name><surname>Bassel-Duby</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21</article-title>. <source>Cancer Cell</source>
<volume>18</volume>: <fpage>282</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2010.08.013</pub-id>
<pub-id pub-id-type="pmid">20832755</pub-id></mixed-citation></ref><ref id="pone.0115855.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Filgueiras</surname><given-names>LR</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Serezani</surname><given-names>AP</given-names></name>, <name><surname>Peters-Golden</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation</article-title>. <source>J Immunol</source>
<volume>192</volume>: <fpage>2349</fpage>&#x02013;<lpage>2356</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302982</pub-id>
<pub-id pub-id-type="pmid">24477912</pub-id></mixed-citation></ref></ref-list></back></article>